Corpus luteum hemorrhages complicating chronic anticoagulation. 1977

J A Perlman, and A B Barnes, and Z Demirjian

A 29-year-old patient with prosthetic replacement of two cardiac valves who was receiving chronic anticoagulation therapy presented with sequential corpus luteum hemorrhages. The problems of reproductive system hemorrhage from chronic anticoagulation therapy are discussed, as well as the specific problemsof women of reproductive age with heart valve replacements. Issues and therapy are considered.

UI MeSH Term Description Entries
D010049 Ovarian Diseases Pathological processes of the OVARY. Disease, Ovarian,Diseases, Ovarian,Ovarian Disease
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D005260 Female Females
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

J A Perlman, and A B Barnes, and Z Demirjian
April 2011, Lupus,
J A Perlman, and A B Barnes, and Z Demirjian
March 1969, Obstetrics and gynecology,
J A Perlman, and A B Barnes, and Z Demirjian
May 1978, Annals of internal medicine,
J A Perlman, and A B Barnes, and Z Demirjian
January 1951, Comptes rendus de la Societe francaise de gynecologie,
J A Perlman, and A B Barnes, and Z Demirjian
January 1953, Archiv fur Gynakologie,
J A Perlman, and A B Barnes, and Z Demirjian
April 2002, Therapeutische Umschau. Revue therapeutique,
J A Perlman, and A B Barnes, and Z Demirjian
April 1992, Current opinion in obstetrics & gynecology,
J A Perlman, and A B Barnes, and Z Demirjian
January 1964, Annales d'endocrinologie,
J A Perlman, and A B Barnes, and Z Demirjian
June 1966, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
J A Perlman, and A B Barnes, and Z Demirjian
April 1980, American journal of obstetrics and gynecology,
Copied contents to your clipboard!